1. Wang Y*, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, Han P, Peng R, Yu H, Lin Y, Gao TL, Shou JW, Li XY, Zhang XF, Zhang ZW, Fu J, Wen BY, Yu JB, Cao XT*, Jiang JD*. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota. Signal Transduct Target Ther. 2021 Feb 24;6(1):1-20.
2. 张正威, 赵朕雄, 王琰*, 蒋建东*. 药物基于“肠-脑”通路的研究进展. 药学学报. 2021, 56(3): 643-653.
3. Dong GM, Yu H, Pan LB, Ma SR, Xu H, Zhang ZW, Han P, Fu J, Yang XY, Keranmu A, Niu HT, Jiang JD*, Wang Y*. Biotransformation of Timosaponin BII into Seven Characteristic Metabolites by the Gut Microbiota. Molecules. 2021 Jun 24;26(13):3861. doi: 10.3390/molecules26133861.
4. Han P, Gu JQ, Li LS, Wang XY, Wang HT, Wang Y*, Chang C*, Sun JL*. The Association between Intestinal Bacteria and Allergic Diseases—Cause or Consequence? Front Cell Infect Microbiol. 2021 Apr 15; 11:650893.
5. Han P, Li LS, Wang ZX, Xi L, Yu H, Cong L, Zhang ZW, Fu J, Peng R, Pan LB, Ma SR. Wang XY, Wang HT*, Wang Y*, Sun JL*, Jiang JD*. Multi-Omics Analysis Provides Insight into the Possible Molecular Mechanism of Hay Fever Based on Gut Microbiota. Engineering. 2021 May 1.
6. Ma SR, Yu JB, Fu J, Pan LB, Yu H, Han P, Zhang ZW, Peng R, Xu H, Wang, Y*. Determination and Application of Nineteen Monoamines in the Gut Microbiota Targeting Phenylalanine, Tryptophan, and Glutamic Acid Metabolic Pathways. Molecules. 2021, 26, 1377.
7. Shang J, Ma S, Zang CX, Bao XQ*, Wang Y*, Zhang D*. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson’s disease treatment. Acta Pharm Sin B. 2021 May;11(5):1213-1226.
8. Zhang ZW, Cong L, Peng R, Han P, Ma SR, Pan LB, Fu J, Yu H, Wang Y*, Jiang JD*. Transformation of Berberine to Its Demethylated Metabolites by the CYP51 Enzyme in the Gut Microbiota. J. Pharm. Anal. 2020 Oct 14. https://doi.org/10.1016/j.jpha.2020.10.001.
9. 解笑瑜,甄雪燕,于航,张正威,王嗣岑*,王琰*,马双成*. 2018年度药物分析技术研究进展. 药物分析杂志, 2020, 40(05):8-25.
10. Pan L, Han P, Ma S, Peng R, Wang C, Kong W, Cong L, Fu J, Zhang Z, Yu H, Wang Y*, Jiang J.D*. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia. Acta Pharm Sin B. 2020 Feb; 10(2):249-261.
11. Peng R, Ma SR, Fu J, Han P, Pan LB, Zhang ZW, Yu H, Wang Y*. Transforming of Triptolide into Characteristic Metabolites by the Gut Microbiota. Molecules. 2020 Jan 30;25(3):606.
12. Wang C, Wang Y, Ma SR, Zuo ZY, Wu YB, Kong WJ*, Wang AP*, Jiang JD*. Berberine inhibits adipocyte differentiation, proliferation and adiposity through down-regulating galectin-3. Sci Rep. 2019 Sep 16; 9(1):13415.
13. Ma SR, Tong Q, Zhao ZX, Cong L, Yu JB, Fu J, Han P, Pan LB, Gu R, Peng R, Zhang ZW, Wang Y*, Jiang JD*. Determination of berberine-upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone. Anal Bioanal Chem. 2019 May;411(14):3191-3207.
14. Yu JB, Zhao ZX, Peng R, Pan LB, Fu J, Ma SR, Han P, Cong L, Zhang ZW, Sun LX, Jiang JD*, Wang Y*. Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin. Front Pharmacol. 2019 Mar 20;10:268.
15. Li C, Chen H, Lan Z, He S, Chen R, Wang F, Liu Z, Li K, Cheng L, Liu Y, Sun K, Wan X, Chen X, Peng H, Li L, Zhang Y, Jing Y, Huang M, Wang Y, Wang Y, Jiang J, Zha X, Chen L*, Zhang H*. mTOR-dependent upregulation of xCT blocks melanin synthesis and promotes tumorigenesis. Cell Death Differ. 2019 Feb 13. doi: 10.1038/s41418-019-0274-0.
16. Zhen-Xiong Zhao, Jie Fu, Shu-Rong Ma, Ran Peng, Jin-Bo Yu, Lin Cong, Li-Bin Pan, Zuo-Guang Zhang, Hui Tian, Chun-Tao Che, Yan Wang*, Jian-Dong Jiang*. Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin. Theranostics. 2018 Nov 13; 8(21):5945-5959.
17. 王琰#, 蒋建东*. 肠道菌介导的PK-PD 新模式: 小檗碱药代动力学引发的思考. 药学学报, 2018, 53 (5): 659−666.
18. Li CH, Tang SC, Wong CH, Wang Y*, Jiang JD*, Chen Y*. Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway. Eur J Pharmacol. 2018 Apr 15; 825:107-118.
19. Feng R, Zhao ZX, Ma SR, Guo F, Wang Y*, Jiang JD*. Gut microbiota-regulated pharmacokinetics of berberine and active metabolites in beagle dogs after oral administration. Front Pharmacol. 2018 Mar 21; 9:214.
20. Yan Wang*, Qian Tong, Jia-Wen Shou, Zhen-Xiong Zhao, Xiao-Yang Li, Xian-Feng Zhang, Shu-Rong Ma, Chi-Yu He, Bao-Ying Wen, Fang Guo, Jie Fu, Jian-Dong Jiang*. Gut microbiota mediated personalized medicine in berberine treatment. Theranostics. 2017, 7(9):2443-2451.
21. Chi-Yu He, Jie Fu, Jia-Wen Shou, Zhen-Xiong Zhao, Long Ren, Yan Wang* and Jian-Dong Jiang*. In vitro study of the metabolic characteristics of eight isoquinoline alkaloids from natural plants in rat gut microbiota. Molecules, 2017, 22: 932.
22. Yan Wang*, Jia-Wen Shou, Xiao-Yang Li, Zhen-Xiong Zhao, Jie Fu, Chi-Yu He, Ru Feng, Chao Ma, Bao-Ying Wen, Fang Guo, Xin-Yi Yang, Yan-Xing Han, Lu-Lu Wang, Qian Tong, Xue-Fu You, Yuan Lin, Wei-Jia Kong, Shu-Yi Si, Jian-Dong Jiang*. Berberine-induced bioactive metabolites of gut microbiota improves energy metabolism. Metabolism, 2017, 70:72–84.
23. 潘利斌, 范辉政, 蒋建东, 王琰*. 微量元素硒的体内过程及生物学效应研究进展. 药学学报, 2017, 52 (12): 1849 −1858.
24. Jian-Li Zhang, Yi-Nong Zhang, Yan Wang*. Validated quantification method for five ephedrines in dietary supplements using LC–MS/MS: Application to 503 cases. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Dec 15; 1039:1-7.
25. Jianli Zhang, Jianghai Lu*, Yun Wu, Xiao-Bing Wang, You-Xuan Xu, Yi-Nong Zhang, Yan Wang*. New potential biomarker for methasterone misuse in human urine by liquid chromatography quadruple time of flight mass spectrometry. Int J Mol Sci. 2016, 17: 4486-4492.
26. Shi-Feng Chu, Shao-Lin Liu, Wen-Zhen Duan, Yong Cheng, Xue-Ying Jiang, Chuan-Jiang Zhu, Kang Tang, Run-Sheng Wang, Lin Xu, Xiao-YingWang, Xiao-Ming Yu, Ke-mei Wu, Yan Wang, Mu-Zou Wang, Hui-Yong Huang, Jun-Tian Zhang. The anti-dementia drug candidate, (−)-clausenamide, improves memory impairment through its multi-target effect. Pharmacology & Therapeutics, 2016, 162: 179-187.
27. Jing-Yi Ma, Xuelin Zhou, Jie Fu, Chi-Yu He, Ru Feng, Min Huang, Jia-Wen Shou, Zhen-Xiong Zhao, Xiao-Yang Li, Luye Zhang, Yang-Chao Chen, Yan Wang*. In vivo metabolite profiling of a purified ellagitannin isolated from Polygonum capitatum in Rats. Molecules, 2016, 21: 1110.
28. Ru Feng, Xiang-Shan Tan, Bao-YingWen, Jia-Wen Shou, Jie Fu, Chi-Yu He, Zhen-Xiong Zhao, Xiao-Yang Li, Hui-Xin Zhu, Ping Zhu, Jian-Gong Shi, Chun-Tao Che, John H.K. Yeung, Xian-Feng Zhang*, Yan Wang*. Interaction effects on cytochrome P450 both in vitro and in vivo studies by two major bioactive xanthones from Halenia elliptica D. Don. Biomedical Chromatography. 2016, 30: 1953-1962.
29. Chi-Yu He, Ru Feng, Yu-Peng Sun, Shi-Feng Chu, Ji Chen, Chao Ma, Jie Fu, Zhen-Xiong Zhao, Min Huang, Jia-Wen Shou, Xiao-Yang Li, Yu-Zhu Wang, Jin- Feng Hu, Yan Wang*, Jun-Tian Zhang*. Simultaneous quantification of ginsenoside Rg1 and its metabolites by high performance liquid chromatography–tandem mass spectrometry: Rg1 excretion in rat bile, urine, and feces. Acta Pharm Sin B. 2016 Nov;6(6):593-599.
30. Bao-Hui Cheng, XuelinZhou, Yan Wang, Judy Yuet-Wa Chan, Huang-Quan Lin, Penelope M.Y. Or, David Chi-Cheong Wan, Ping-Chung Leung, Kwok-Pui Fung, Yi-Fen Wang, Clara Bik-San Lau. Herb–drug interaction between an anti-HIV Chinese herbal SH formula and a tazanavir in vitro and in vivo. J Ethnopharmacol, 2015 Mar 13; 162:369-76.